Green Thumb Industries (GTII) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
23 Apr, 2026Executive summary
First quarter 2025 revenue reached $280 million, up 1.4% year-over-year, despite ongoing pricing pressures and macroeconomic uncertainty from tariffs and regulatory ambiguity.
Adjusted EBITDA was $85.2 million (30.5% of revenue), down from $90.5 million (32.8%) in the prior year, with cash flow from operations at $74 million, reflecting operational resilience.
Net income was $8.3 million ($0.04 per diluted share), down from $31.1 million ($0.13 per share) in the prior year, impacted by a prior year fair value adjustment.
The company maintains a strong balance sheet and is focused on long-term growth, capitalizing on shifting consumer trends favoring THC over alcohol.
Opened two new RISE Dispensaries in Nevada and Ohio, with grand opening profits donated to local charities.
Financial highlights
Revenue grew 1.4% year-over-year to $280 million, driven by a 14% increase in consumer packaged goods sales, while retail revenue declined due to pricing pressures.
Gross profit was $143.3 million (51.3% margin), down from $145 million (53% margin) last year, primarily due to price compression.
Retail revenue decreased 2.5% year-over-year, mainly from price compression in Illinois, Pennsylvania, New Jersey, and Connecticut, partially offset by growth in Ohio and New York.
Comparable store sales (stores open at least 12 months) declined 5.3% year-over-year on a base of 90 stores.
Total SG&A expenses were $100.8 million (36.1% of revenue), up from $74.3 million (26.9%) in Q1 2024, reflecting the absence of a prior year $15.9 million non-cash credit.
Outlook and guidance
Second quarter sequential revenue is expected to be flat due to continued pricing challenges.
Adjusted EBITDA margin is projected to fall below 30% in coming quarters as pricing pressures persist.
Capital expenditures for 2025 are expected to be approximately $80 million, in line with the prior year.
No expectation for sweeping federal cannabis reform in the near term; focus remains on operational efficiency and selective market investments.
Teams are preparing for the launch of adult-use sales in Minnesota, expected before year-end.
Latest events from Green Thumb Industries
- Q3 revenue up 4% to $287M, Adjusted EBITDA margin 31.1%, strong cash flow and liquidity.GTII
Q3 202423 Apr 2026 - Revenue rose 3.4% in 2025, with strong cash flow and retail expansion offset by margin pressure.GTII
Q4 202525 Feb 2026 - Q2 revenue up 4.7% to $293.3M, but margins pressured by price compression and regulatory headwinds.GTII
Q2 20253 Feb 2026 - Q2 revenue up 11% to $280M, net income $21M, adjusted EBITDA $94M; strong retail growth.GTII
Q2 20242 Feb 2026 - Record revenue, EBITDA, and cash flow drive growth amid pricing and regulatory challenges.GTII
Q4 202423 Dec 2025 - All resolutions, including board elections and plan amendments, passed with no shareholder questions.GTII
AGM 202516 Dec 2025 - Q3 2025 saw modest revenue growth, strong cash flow, and continued share repurchases.GTII
Q3 20255 Nov 2025 - Cannabis market growth and strong financials drive expansion across 14 states and 104 stores.GTII
Investor Presentation18 Jun 2025